Pseudomyxoma peritonei - Two novel orthotopic mouse models portray the PMCA-I histopathologic subtype

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Flatmark, Kjersti ^a,b   Reed, Wenche ^a   Halvorsen, Thomas ^a   Sørensen, Olaf ^a   Wiig, Johan N ^a   Larsen, Stein G ^a   Fodstad, Øystein ^a,b   Giercksky, Karl Erik ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; KI 67 ANTIGEN; MUCIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER MODEL; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUDE MOUSE; PERITONEAL CAVITY; PERITONEUM PSEUDOMYXOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPRODUCIBILITY; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE MODEL; METABOLISM; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; TIME; XENOGRAFT;

AGED, 80 AND OVER; ANIMALS; CARCINOEMBRYONIC ANTIGEN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KERATIN-20; KERATIN-7; KI-67 ANTIGEN; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MUCINS; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34547470627     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-116     Document Type: Article

References (15)

1. Ronnett BM Shmookler BM Diener-West M Sugarbaker PH Kurman RJ Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women International Journal of Gynecological Pathology 1997 16 1 1-9 10.1097/00004347-199701000-00001 8986525
2. Guerrieri C Franlund B Fristedt S Gillooley JF Boeryd B Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression Human Pathology 1997 28 9 1039-1045 10.1016/S0046-8177(97)90057-5 9308728
3. Cuatrecasas M Matias-Guiu X Prat J Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations The American journal of surgical pathology 1996 20 6 739-746 10.1097/00000478-199606000-00012 8651354
4. Szych C Staebler A Connolly DC Wu R Cho KR Ronnett BM Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women The American journal of pathology 1999 154 6 1849-1855 1866622 10362811
5. Young RH Gilks CB Scully RE Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix The American journal of surgical pathology 1991 15 5 415-429 10.1097/00000478-199105000-00001 2035736
6. Smeenk RM Verwaal VJ Zoetmulder FA Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures European Journal of Surgical Oncology 2006 32 2 186-190 10.1016/ j.ejso.2005.08.009 16303281
7. Miner TJ Shia J Jaques DP Klimstra DS Brennan MF Coit DG Long-term survival following treatment of pseudomyxoma peritonei: An analysis of surgical therapy Annals of surgery 2005 241 2 300-308 1356916 15650641 10.1097/01.sla.0000152015.76731.1f
8. Ronnett BM Yan H Kurman RJ Shmookler BM Wu L Sugarbaker PH Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis Cancer 2001 92 1 85-91 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R 11443613
9. Yan TD Links M Xu ZY Kam PC Glenn D Morris DL Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms The British journal of surgery 2006 93 10 1270-1276 10.1002/bjs.5427 16838392
10. Maheshwari V Tsung A Lin Y Zeh HJ 3rd Finkelstein SD Bartlett DL Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix Ann Surg Oncol 2006 17009159
11. Bradley RF Stewart JH Russell GB Levine EA Geisinger KR Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review The American journal of surgical pathology 2006 30 5 551-559 10.1097/01.pas.0000202039.74837.7d 16699309
12. Alexander-Sefre F Chandrakumaran K Banerjee S Sexton R Thomas JM Moran B Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence Colorectal Dis 2005 7 4 382-386 10.1111/j.1463-1318.2005.00773.x 15932563
13. Bibi R Pranesh N Saunders MP Wilson MS O'Dwyer S T Stern PL Renehan AG A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei British journal of cancer 2006 95 9 1258-1264 10.1038/sj.bjc.6603398 17031402
14. Brown DC Gatter KC Ki67 protein: The immaculate deception? Histopathology 2002 40 1 2-11 10.1046/j.1365-2559.2002.01343.x 11903593
15. Yakushiji M Miyahara K Nishimura H Iwanaga S Kato T Transplantation of human ovarian pseudomyxoma peritonei to nude mice and sensitivity to anticancer agents Asia-Oceania journal of obstetrics and gynaecology/ AOFOG 1987 13 1 113-119 3593079